Researchers from King's College London and University College London have discovered that alterations in the structural network of lymph nodes can signal breast cancer risk before cancer cells are detectable. This study analyzed 331 lymph node samples, revealing that changes in fibroblastic reticular cells (FRCs) can vary depending on cancer type and treatment. The findings suggest that some structural changes may correlate with better survival rates, while others could indicate a worse prognosis. Currently, all patients with invasive breast cancer undergo lymph node removal, which can result in long-term complications such as lymphoedema. Dr. Simon Vincent from Breast Cancer Now emphasized the need for this research to better understand cancer progression and to identify patients who may not require invasive procedures. The study highlights the potential for more tailored treatments and the reduction of unnecessary side effects. Ruth Smith, a breast cancer survivor, shared her experience with lymphoedema, underscoring the importance of research that could lead to improved treatment strategies. The findings are published in the Journal of Pathology.